1994
DOI: 10.1016/0014-2999(94)90262-3
|View full text |Cite
|
Sign up to set email alerts
|

Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0

Year Published

1996
1996
2013
2013

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(19 citation statements)
references
References 31 publications
0
19
0
Order By: Relevance
“…Morphine enhances the release of adenosine from the spinal cord and cortex (Phillis et al, 1980;Cahill et al, 1996), presumably through a synergistic activation of and ␦ opioid receptors (Cahill et al, 1996). Pharmacological studies have indicated that the A 1 and A 2A receptors may be downstream mediators of morphine analgesia (Keil and DeLander, 1994;Sawynok, 1998), although studies in A 2A knockout mice failed to reveal any differences in receptor-dependent analgesia (Bailey et al, 2002). The results from this study indicate that the analgesic effects of centrally released adenosine may be counterbalanced by pronociceptive A 2B receptor-mediated peripheral effects of adenosine.…”
Section: Discussionmentioning
confidence: 99%
“…Morphine enhances the release of adenosine from the spinal cord and cortex (Phillis et al, 1980;Cahill et al, 1996), presumably through a synergistic activation of and ␦ opioid receptors (Cahill et al, 1996). Pharmacological studies have indicated that the A 1 and A 2A receptors may be downstream mediators of morphine analgesia (Keil and DeLander, 1994;Sawynok, 1998), although studies in A 2A knockout mice failed to reveal any differences in receptor-dependent analgesia (Bailey et al, 2002). The results from this study indicate that the analgesic effects of centrally released adenosine may be counterbalanced by pronociceptive A 2B receptor-mediated peripheral effects of adenosine.…”
Section: Discussionmentioning
confidence: 99%
“…As in epilepsy, adenosine provides potent inhibition to hyperexcitable neuronal circuits resulting in profound antinociceptive effects of adenosine (Lynch et al, 2003;Sawynok and Liu, 2003). Consequently, ADK inhibitors have been considered as a very attractive target for the treatment of various pain states, and proof of feasibility studies with prototypes of ADK inhibitors have demonstrated efficacy in several animal models of nociception (Keil and DeLander, 1994;Sawynok, 1995, 1998;Sawynok and Liu, 2003). Unfortunately, short half lives in vivo, poor bioavailability, lack of pharmacological selectivity, and potential to form cytotoxic metabolites limited further preclinical testing of those prototype inhibitors (Cottam et al, 1993;Wiesner et al, 1999;Ugarkar et al, 2000a).…”
Section: B Applications In Preclinical Studiesmentioning
confidence: 99%
“…The tail-flick model involves spinal nociceptive reflex, thus being suitable for the study of the adenosinergic influence in spinal cord (29). Rats were wrapped in a towel and placed on the apparatus.…”
Section: Tail-flick Measurementmentioning
confidence: 99%